Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Breast cancer chemotherapy induces vascular dysfunction and hypertension through a NOX4-dependent mechanism
Piotr Szczepaniak, … , David G. Harrison, Tomasz J. Guzik
Piotr Szczepaniak, … , David G. Harrison, Tomasz J. Guzik
Published May 26, 2022
Citation Information: J Clin Invest. 2022;132(13):e149117. https://doi.org/10.1172/JCI149117.
View: Text | PDF
Research Article Vascular biology Article has an altmetric score of 79

Breast cancer chemotherapy induces vascular dysfunction and hypertension through a NOX4-dependent mechanism

  • Text
  • PDF
Abstract

Cardiovascular disease is the major cause of morbidity and mortality in breast cancer survivors. Chemotherapy contributes to this risk. We aimed to define the mechanisms of long-term vascular dysfunction caused by neoadjuvant chemotherapy (NACT) and identify novel therapeutic targets. We studied arteries from postmenopausal women who had undergone breast cancer treatment using docetaxel, doxorubicin, and cyclophosphamide (NACT) and from women with no history of such treatment matched for key clinical parameters. We explored mechanisms in WT and Nox4–/– mice and in human microvascular endothelial cells. Endothelium-dependent, NO-mediated vasodilatation was severely impaired in patients after NACT, while endothelium-independent responses remained normal. This was mimicked by a 24-hour exposure of arteries to NACT agents ex vivo. When applied individually, only docetaxel impaired endothelial function in human vessels. Mechanistic studies showed that NACT increased inhibitory eNOS phosphorylation of threonine 495 in a Rho-associated protein kinase–dependent (ROCK-dependent) manner and augmented vascular superoxide and hydrogen peroxide production and NADPH oxidase activity. Docetaxel increased expression of the NADPH oxidase NOX4 in endothelial and smooth muscle cells and NOX2 in the endothelium. A NOX4 increase in human arteries may be mediated epigenetically by diminished DNA methylation of the NOX4 promoter. Docetaxel induced endothelial dysfunction and hypertension in mice, and these were prevented in Nox4–/– mice and by pharmacological inhibition of Nox4 or Rock. Commonly used chemotherapeutic agents and, in particular, docetaxel alter vascular function by promoting the inhibitory phosphorylation of eNOS and enhancing ROS production by NADPH oxidases.

Authors

Piotr Szczepaniak, Mateusz Siedlinski, Diana Hodorowicz-Zaniewska, Ryszard Nosalski, Tomasz P. Mikolajczyk, Aneta M. Dobosz, Anna Dikalova, Sergey Dikalov, Joanna Streb, Katarzyna Gara, Pawel Basta, Jaroslaw Krolczyk, Joanna Sulicka-Grodzicka, Ewelina Jozefczuk, Anna Dziewulska, Blessy Saju, Iwona Laksa, Wei Chen, John Dormer, Maciej Tomaszewski, Pasquale Maffia, Marta Czesnikiewicz-Guzik, Filippo Crea, Agnieszka Dobrzyn, Javid Moslehi, Tomasz Grodzicki, David G. Harrison, Tomasz J. Guzik

×

Figure 3

Vascular effects of docetaxel and the role of oxidative stress in NACT-induced endothelial dysfunction.

Options: View larger image (or click on image) Download as PowerPoint
Vascular effects of docetaxel and the role of oxidative stress in NACT-i...
(A) Schematic design of ex vivo organ culture study of the effects of 24 hours of docetaxel on the gene expression profile using RNA-Seq. Volcano plot shows examples of significantly altered genes related to vascular biology and oxidative stress in NACT-naive arteries after a 24-hour organ culture with docetaxel (100 nM) in comparison with exposure to vehicle (red: adjusted P value [Padj] < 0.05). Bar charts present the GSEA (–log10 P values) of selected docetaxel-downregulated (blue) and -upregulated (yellow) pathways (n = 6/group). *Padj < 0.05, FDR. Enrichment is expressed as the normalized enrichment score (NES). (B) Effect of NAC (1 mM) on endothelium-dependent vasorelaxation responses to ACh in arteries from patients with or without prior neoadjuvant chemotherapy (NACT versus no NACT; n = 5/group). Data are expressed as the mean ± SEM. ***P < 0.001 versus NACT; 2-way, repeated-measures ANOVA. (C) Superoxide production was measured using lucigenin (LGCL; 5 μM) in arteries from patients with (n = 27) or without (n = 37) prior NACT. **P < 0.01 versus no NACT. (D) EPR of NADPH-dependent superoxide production in membrane fractions of arteries from patients with or without prior NACT; example time scans of CP-nitroxide accumulation using CPH (1-hydroxy-3-carboxy-2,2,5,-tetramethyl-pyrrolidine hydrochloride; 1.0 mM) and NADPH (0.2 mM). Insert shows the initial EPR spectrum of the spin probe CPH; arrow indicates the low-field component used to follow the nitroxide accumulation. (D, right) Data indicate the mean ± SEM of NADPH oxidase (Nox) activity (n = 10/group). ***P < 0.001, versus no NACT. (E) H2O2 production using Amplex Red (n = 6/group; mean ± SEM). **P < 0.01 versus no NACT; 2-tailed, unpaired Student’s t test (C–E). (F) Microphotographs of fluorescence detection of superoxide (DHE; 10 μM) and H2O2 production (DCFH-DA; 10 μM) in arteries from patients with or without prior NACT. PEG-SOD (500 U/mL) and PEG-CAT (500 U/mL) were used to show signal specificity for superoxide and H2O2, respectively (representative of 5/group). Scale bars: 100 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 4 news outlets
Blogged by 1
Posted by 68 X users
44 readers on Mendeley
See more details